Articles

• The need for neuroprotective therapies in Parkinson’s diseaseA clinical perspective

  Werner Poewe

  • Abstract
  • Full Text
• Etiology of Parkinson’s disease

  Anthony H.V. Schapira

  • Abstract
  • Full Text
• The pathogenesis of cell death in Parkinson's disease

  Peter Jenner, C. Warren Olanow

  • Abstract
  • Full Text
• Proteasomal dysfunction in sporadic Parkinson's disease

  Kevin St. P. McNaught, Tehone Jackson, Ruth JnoBaptiste, Alexander Kapustin, C. Warren Olanow

  • Abstract
  • Full Text
• Issues in neuroprotection clinical trials in Parkinson’s disease

  Karl Kieburtz

  • Abstract
  • Full Text
• Clinical trials aimed at detecting neuroprotection in Parkinson’s disease

  Robert A. Hauser, Theresa A. Zesiewicz

  • Abstract
  • Full Text
• Rationale for considering that propargylamines might be neuroprotective in Parkinson’s disease

  C. Warren Olanow

  • Abstract
  • Full Text
• Clinical trials with rasagilineEvidence for short-term and long-term effects

  Andrew Siderowf, Matthew Stern

  • Abstract
  • Full Text
• Gene transfer of trophic factors and stem cell grafting as treatments for Parkinson’s disease

  Biplob Dass, C. Warren Olanow, Jeffrey H. Kordower

  • Abstract
  • Full Text